Regeneron Rips DOJ's FCA Suit As 'Divorced From Reality'
Law 360
JULY 19, 2024
has told a Massachusetts federal judge that a False Claims Act suit brought by the U.S. Department of Justice claiming the company withheld information about a drug's average sales price was "divorced from reality" and the practice the government was complaining about was commonplace. Regeneron Pharmaceuticals Inc.
Let's personalize your content